These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Filed by the Registrant
ý
|
||
|
Filed by a Party other than the Registrant
o
|
||
|
Check the appropriate box:
|
||
|
o
|
Preliminary Proxy Statement
|
|
|
o
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
ý
|
Definitive Proxy Statement
|
|
|
o
|
Definitive Additional Materials
|
|
|
o
|
Soliciting Material Pursuant to §240.14a-12
|
|
|
Payment of Filing Fee (Check the appropriate box):
|
|
|
ý
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
(1) Title of each class of securities to which transaction applies:
|
|
|
(2) Aggregate number of securities to which transaction applies:
|
|
|
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4) Proposed maximum aggregate value of transaction:
|
|
|
(5) Total fee paid:
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
(1) Amount Previously Paid:
|
|
|
(2) Form, Schedule or Registration Statement No.:
|
|
|
(3) Filing Party:
|
|
|
(4) Date Filed:
|
|
1.
|
The election of eight directors named in the proxy statement;
|
|
2.
|
The approval, on an advisory (non-binding) basis, of an advisory resolution on the compensation of the Company’s named executive officers, as disclosed in this proxy statement;
|
|
3.
|
The ratification of the appointment of Deloitte & Touche LLP to serve as the Company’s independent auditor for fiscal year ending June 30, 2016; and
|
|
4.
|
To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
|
|
|
By order of the Board of Directors,
|
|
|
|
|
|
|
|
|
|
|
|
Jules P. Kaufman
|
|
|
|
|
|
Senior Vice President, General Counsel and Secretary
|
||
|
Table of Contents
|
|
|
|
|
|
Questions and Answers about the Proxy Materials and the Annual Meeting
|
|
|
Corporate Governance
|
|
|
Structure of our Board
|
|
|
Board Meetings
|
|
|
Board Qualifications and Membership Criteria
|
|
|
Director Nomination Process
|
|
|
Director Independence
|
|
|
Communications with our Board
|
|
|
Our Board’s Role in Risk Oversight
|
|
|
Board Attendance at the Annual Meeting
|
|
|
Compensation Committee Interlocks and Insider Participation
|
|
|
Certain Relationships and Related Party Transactions
|
|
|
Proposal No. 1: Election of Directors
|
|
|
Directors
|
|
|
Director Compensation
|
|
|
Executive Officers
|
|
|
Security Ownership of Certain Beneficial Owners and Management
|
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
|
|
Proposal No. 2: Approval of Advisory Resolution on NEO Compensation (Say-On-Pay)
|
|
|
Compensation Discussion and Analysis
|
|
|
Remuneration and Nomination Committee Report
|
|
|
Audit and Finance Committee Report
|
|
|
Proposal No. 3: 2015 Ratification of Appointment of Deloitte & Touche LLP as our Independent Auditor
|
|
|
Audit Fees and Other Fees
|
|
|
Stockholder Proposals for the 2016 Annual Meeting
|
|
|
Other Matters
|
|
|
|
|
|
Proposal
|
|
Voting
Options
|
|
Vote Required to Adopt the Proposal
|
|
Effect of Abstentions or Withhold Votes (if Applicable)
|
|
Effect of “Broker
Non-Votes”
|
|
Board Recommendation
|
|
Proposal 1: Election of Directors
|
|
For All,
Withhold All, or For All Except.
|
|
A plurality of votes - nominees receiving the highest number of affirmative votes will be elected (up to the total number of available board seats).
|
|
No effect.
|
|
No effect.
|
|
Our Board recommends a vote
FOR
each director.
|
|
Proposal 2: Approval of Advisory Resolution on Named Executive Officer (“NEO”) Compensation
|
|
For, against, or abstain.
|
|
The affirmative vote of a majority of the votes cast.
|
|
No effect.
|
|
No effect.
|
|
Our Board recommends a vote
FOR
the approval of the advisory resolution on NEO compensation.
|
|
Proposal 3: Ratification of Appointment of Deloitte & Touche LLP (“Deloitte”) as our independent auditor
|
|
For, against, or abstain.
|
|
The affirmative vote of a majority of the votes cast.
|
|
No effect.
|
|
Brokers have discretion to vote.
|
|
Our Board recommends a vote
FOR
ratification.
|
|
•
|
giving written notice to our Corporate Secretary revoking your proxy;
|
|
•
|
by submitting a later-dated proxy by telephone or electronically before 11:59 p.m. EST on November 3, 2015;
|
|
•
|
by a later-dated mailed proxy received before the close of the Annual Meeting on November 4, 2015; or
|
|
•
|
by voting online at the Annual Meeting.
|
|
•
|
monitoring the integrity of our financial reporting process and systems of internal controls regarding finance, accounting, and compliance with our Code and laws and regulations;
|
|
•
|
being responsible for the appointment, compensation, retention and oversight of the work of our independent auditors and assessing and monitoring the independence and performance of our independent auditors and internal audit department;
|
|
•
|
providing an objective, direct communication between our Board, independent auditors, management and the internal audit department;
|
|
•
|
reviewing and pre-approving both audit and non-audit services to be provided by our independent auditors and establishing policies and procedures for the pre-approval of audit and non-audit serves to be provided by the independent auditors;
|
|
•
|
meeting to review the audited and quarterly financial statements and discussing these statements with management and our independent auditors, including reviewing the Company’s specific disclosures under the
|
|
•
|
establishing procedures for the review, approval and ratification of related person transactions; and
|
|
•
|
overseeing the Company’s risk management policies and reviewing and evaluating the risk management policies in light of the Company’s business strategy, capital strength and overall risk tolerance.
|
|
•
|
identifying individuals qualified to become Board members (consistent with criteria recommended by the RNC and approved by the Board) and recommending to our Board nominees for election at the annual meeting of stockholders and nominees for each board committee;
|
|
•
|
reviewing and making recommendations to our Board concerning board committee structure, operations and Board reporting;
|
|
•
|
discharging our Board’s responsibilities relating to the remuneration of our senior executives, including our Chief Executive Officer;
|
|
•
|
approving and evaluating our executive remuneration plans, policies and programs and ensuring that these plans, policies and programs enable us to attract and retain exceptional talents and incentivize them to achieve exceptional performance;
|
|
•
|
overseeing succession planning for our senior executives, including our Chief Executive Officer, and guiding our Board in appointing and retaining key talents that will nurture our values and culture and strive for constantly improving results;
|
|
•
|
recommending to our Board the corporate governance principles, annually reviewing them and recommending changes to the Board as appropriate;
|
|
•
|
reviewing and making recommendations with respect to the remuneration of all directors;
|
|
•
|
assessing the results of the Company’s most recent advisory vote on executive compensation;
|
|
•
|
reviewing and discussing with management the Company’s compensation discussion and analysis and SEC-required disclosures and recommending to the Board based on that review and discussion whether the compensation discussion and analysis should be included in the Company’s annual report on Form 10-K and/or proxy statement;
|
|
•
|
preparing the compensation committee report required by SEC rules to be included in the Company’s annual report on Form 10-K and/or proxy statement; and
|
|
•
|
overseeing the evaluation of the performance of our Board and management.
|
|
•
|
the director is, or has been within the last three years, our employee, or an immediate family member of the director is, or has been within the last three years, our executive officer;
|
|
•
|
the director has received, or has an immediate family member who has received, during any 12-month period during the last three years, more than $120,000 in direct compensation from us (other than
|
|
•
|
(a) the director, or an immediate family member of the director, is a current partner of our internal or external auditor; (b) the director is a current employee of our internal or external auditor; (c) an immediate family member of the director is a current employee of our internal or external auditor who personally works on our audit; or (d) the director, or an immediate family member of the director, was within the last three years (but is no longer) a partner or employee of our internal or external auditor and personally worked on our audit within that time;
|
|
•
|
the director, or an immediate family member of the director, is, or has been within the last three years, employed as an executive officer of another company where any of our present executive officers serves or served at the same time on that company’s compensation committee;
|
|
•
|
the director is a current employee, or an immediate family member of the director is a current executive officer, of a company that has made payments to, or received payments from, us for property or services in an amount that, in any of the last three fiscal years, exceeds the greater of $1 million or 2% of the other company’s consolidated gross revenues; or
|
|
•
|
the director, or the director’s spouse, is an executive officer of a non-profit organization to which we make, or in the past three years have made, payments that, in any single fiscal year, exceeded the greater of $1 million or 2% of the non-profit organization’s consolidated gross revenues.
|
|
•
|
certain types of executive officer compensation;
|
|
•
|
compensation paid to a director if required to be reported in our Proxy Statement;
|
|
•
|
any transaction with another company to which a related person’s only relationship is as an employee (other than an executive officer), or as a director or beneficial owner of a less than 10% (together with all other related persons) equity interest in that company, or both, if the amount involved does not exceed the greater of $1 million or 2% of that company’s total annual revenue;
|
|
•
|
any charitable contribution, grant, or endowment by us to a charitable organization, foundation, or university to which a related person’s only relationship is as an employee (other than an executive officer) or a director, if the amount involved does not exceed the lesser of $1 million or 2% of the charitable organization’s total annual receipts;
|
|
•
|
any related person transaction where the related person’s interest arises solely from the ownership of our Common Stock and in which all stockholders receive proportional benefits; and
|
|
•
|
any related person transaction in which the rates or charges involved are determined by competitive bids.
|
|
Name
|
|
Age
|
|
Director Since
|
|
Lambertus J.H. Becht
|
|
59
|
|
2011
|
|
Joachim Faber
|
|
65
|
|
2010
|
|
Olivier Goudet
|
|
50
|
|
2013
|
|
Peter Harf
|
|
69
|
|
1996
|
|
Paul S. Michaels
|
|
63
|
|
2015
|
|
Erhard Schoewel
|
|
66
|
|
2006
|
|
Robert Singer
|
|
63
|
|
2010
|
|
Jack Stahl
|
|
62
|
|
2011
|
|
Name
|
|
Fees Earned or
Paid in Cash ($) (1) |
|
Stock
Awards ($) (2) |
|
Total ($)
|
||||||
|
Lambertus J.H. Becht
|
(4)
|
|
400,000
|
|
|
|
574,500
|
|
|
|
974,500
|
|
|
Joachim Faber
|
(4)
|
|
100,000
|
|
|
|
191,500
|
|
|
|
291,500
|
|
|
Olivier Goudet
|
(4)
|
|
100,000
|
|
|
|
191,500
|
|
|
|
291,500
|
|
|
Peter Harf
|
(4)
|
|
100,000
|
|
|
|
191,500
|
|
|
|
291,500
|
|
|
Paul S. Michaels
|
(4)
|
|
6,849
|
|
(3)
|
|
17,577
|
|
(3)
|
|
24,426
|
|
|
Erhard Schoewel
|
(4)
|
|
100,000
|
|
|
|
191,500
|
|
|
|
291,500
|
|
|
Robert Singer
|
(4)
|
|
130,000
|
|
|
|
191,500
|
|
|
|
321,500
|
|
|
Jack Stahl
|
(4)
|
|
100,000
|
|
|
|
191,500
|
|
|
|
291,500
|
|
|
(1
|
)
|
|
The amount represents annual cash compensation for service as a director, Chairman or AFC Chair, as applicable. The amount does not include any compensation paid to Mr. Becht for his service as interim CEO, which compensation is reported in the Summary Compensation Table on page 34.
|
||||||||||||||||
|
(2
|
)
|
|
Amount represents the aggregate grant date fair value calculated in accordance with FASB ASC Topic 718 for restricted stock units issued to non-employee directors on November 15, 2014. See Note 23, “Share-Based Compensation Plans” in the notes to our Consolidated Financial Statements in our Annual Report for certain assumptions used to calculate the valuation.
|
||||||||||||||||
|
(3
|
)
|
|
Mr. Michaels received a pro rata fee of $6,849 and RSU grant valued at $17,577 for his service on our Board, which commenced on June 6, 2015.
|
||||||||||||||||
|
(4
|
)
|
|
Presented below are the aggregate number of shares of Class A Common Stock underlying RSUs and stock options held by the directors as of June 30, 2015.
|
||||||||||||||||
|
Name
|
|
Total Number of Shares of Class A Common Stock Underlying RSUs Outstanding as of June 30, 2015
|
|
Total Number of Shares of Class A Common Stock Underlying Stock Options Outstanding as of June 30, 2015
|
|
Lambertus J.H. Becht
|
|
112,500
|
|
—
|
|
Joachim Faber
|
|
44,167
|
|
—
|
|
Olivier Goudet
|
|
21,666
|
|
—
|
|
Peter Harf
|
|
62,500
|
|
—
|
|
Paul S. Michaels
|
|
685
|
|
—
|
|
Erhard Schoewel
|
|
50,000
|
|
—
|
|
Robert Singer
|
|
58,335
|
|
—
|
|
Jack Stahl
|
|
40,000
|
|
—
|
|
Name
|
|
Age
|
|
Position(s) Held
|
|
Lambertus J.H. Becht
|
|
59
|
|
Interim Chief Executive Officer
|
|
Patrice de Talhouët
|
|
49
|
|
Chief Financial Officer
|
|
Sebastien Froidefond
|
|
47
|
|
Senior Vice President of Human Resources
|
|
Jules P. Kaufman
|
|
57
|
|
Senior Vice President, General Counsel and Secretary
|
|
Ralph Macchio
|
|
58
|
|
Senior Vice President of Global Research and Development, Chief Scientific Officer
|
|
Jean Mortier
|
|
55
|
|
President of Global Markets
|
|
Camillo Pane
|
|
45
|
|
Executive Vice President, Category Development
|
|
Mario Reis
|
|
56
|
|
Executive Vice President, Supply Chain
|
|
Kevin Monaco
|
|
51
|
|
Senior Vice President, Treasurer and Investor Relations
|
|
Thomas Muench
|
|
49
|
|
Senior Vice President, Group Controller
|
|
Common Stock Beneficially Owned
|
||||||||||||||
|
Name of Beneficial Owner
|
|
Class A
(1)
|
|
Class B
|
|
% of Total
Voting Power
|
||||||||
|
Shares
|
|
%
|
|
Shares
|
|
%
|
|
|||||||
|
JAB Cosmetics B.V.
|
|
4,447,871
|
|
(2)
|
4.6
|
|
262,062,370
|
|
(2)
|
100
|
|
|
96.6
|
|
|
Mousseluxe S.á.r.l.
|
|
15,562,993
|
|
(3)
|
16.1
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Putnam Investments, LLC
|
|
7,448,605
|
|
(4)
|
7.7
|
|
—
|
|
|
—
|
|
|
*
|
|
|
FMR LLC
|
|
5,319,610
|
|
(5)
|
5.5
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Lambertus J.H. Becht
|
|
4,668,810
|
|
|
4.8
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Patrice de Talhouët
|
|
207,297
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Joachim Faber
|
|
190,500
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Olivier Goudet
|
|
15,000
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Peter Harf
|
|
4,550,719
|
|
|
4.7
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Jules P. Kaufman
|
|
658,428
|
|
(6)
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Paul S. Michaels
|
|
0
|
|
|
0
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Jean Mortier
|
|
797,405
|
|
(7)
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Mario Reis
|
|
126,000
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Michele Scannavini
|
|
0
|
|
|
0
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Erhard Schoewel
|
|
343,991
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Robert Singer
|
|
48,335
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
Jack Stahl
|
|
14,000
|
|
|
*
|
|
—
|
|
|
—
|
|
|
*
|
|
|
All Directors and Executive Officers as a Group (17 persons)
|
|
12,172,663
|
|
(8)
|
12.4
|
|
—
|
|
|
—
|
|
|
*
|
|
|
*
|
|
|
Less than one percent
|
||||||||||||||||
|
(1
|
)
|
|
Includes shares of Class A Common Stock subject to Stock Options that are currently exercisable or exercisable within, and RSUs, if any, that are vested but not settled or that will vest and are expected to settle within 60 days of September 10, 2015.
|
||||||||||||||||
|
(2
|
)
|
|
Based on Forms 4 filed by JAB Cosmetics B.V. on July 10, 2015, and on September 14, 2014, reflecting beneficial ownership as of September 10, 2015. Lucresca, Agnaten, each of which is a company with its registered seat in Austria, and JAB Holdings B.V., a Netherlands corporation, indirectly have voting and investment control over the shares held by JAB Cosmetics B.V., a Netherlands corporation. JAB Cosmetics B.V. is direct subsidiary of JAB Holdings B.V. and an indirect subsidiary of Agnaten and Lucresca. Lucresca and Agnaten are each controlled by Renate Reimann-Haas, Wolfgang Reimann, Stefan Reimann-Andersen and Matthias Reimann-Andersen, who with Peter Harf, Bart Becht and Olivier Goudet exercise voting and investment authority over the shares held by JAB Cosmetics B.V. Lucresca, Agnaten, and JAB Cosmetics B.V. disclaim the existence of a “group” and disclaim beneficial ownership of these securities except to the extent of a pecuniary interest therein. The address of Lucresca and Agnaten is Rooseveltplatz 4-5/Top 10, 1090 Vienna and the address of JAB Cosmetics B.V. and JAB Holdings B.V. is Oudeweg 147, 2031 CC Haarlem, The Netherlands.
|
||||||||||||||||
|
(3
|
)
|
|
Based on a Form 4 filed on June 29, 2015. Represents shares of Class A Common Stock beneficially owned by Mousseluxe S.à.r.l. These shares are indirectly owned by Charles Heilbronn, who has been granted a power of attorney and proxy to exercise voting and investment power with respect to these shares. Mousseluxe S.à.r.l. and Mr. Heilbronn have shared voting and dispositive power over these shares. The address for Mousseluxe S.à.r.l. is 65 Boulevard Grande Duchesse Charlotte, L-1331 Luxembourg. Address for Mr. Heilbronn is c/o Mousse Partners Limited, 9 West 57th Street, New York, NY 10019.
|
||||||||||||||||
|
(4
|
)
|
|
Based solely on a Schedule 13G/A filed on June 10, 2015. Represents shares of Class A Common Stock beneficially owned by Putnam Investments, LLC (“Putnam”) which wholly owns two registered investment advisers: Putnam Investments Management, LLC (“PIM”), which is the investment adviser to the Putnam family of mutual funds and the Putnam Advisory Company, LLC (“PAC” together with Putnam and PIM, the “Putnam Group”), which is the investment adviser to Putnam’s institutional clients. Putnam has sole voting power over 960,997 shares and sole dispositive power over 7,448,605 shares, PIM has sole voting power over 305,279 shares and sole dispositive power over 6,791,808 shares, and PAC has sole voting power over 655,718 shares and sole dispositive power over 656,797 shares. The address for the Putnam Group is One Post Office Square, Boston, MA 02109.
|
||||||||||||||||
|
(5
|
)
|
|
Based solely on a Schedule 13G/A filed on May 11, 2015. Represents shares of Class A Common Stock beneficially owned by FMR LLC. FMR LLC has sole voting power of 51,200 shares and sole dispositive power over 5,319,610 shares. The address for FMR LLC is 245 Summer Street, Boston, MA 02210.
|
||||||||||||||||
|
(6
|
)
|
|
Includes 260,250 shares of Class A Common Stock issuable upon exercise of vested options and 170,000 shares of Class A Common Stock underlying options that vested on September 14, 2015.
|
||||||||||||||||
|
(7
|
)
|
|
Includes 454,700 shares of Class A Common Stock issuable upon exercise of vested options and 115,000 shares of Class A Common Stock underlying options that vested on September 14, 2015.
|
||||||||||||||||
|
(8
|
)
|
|
Includes 1,349,050 shares of Class A Common Stock issuable upon exercise of vested options and 710,000 shares of Class A Common Stock underlying options that vested on September 14, 2015.
|
||||||||||||||||
|
Avon Products, Inc.
|
|
Kimberly Clark Corporation
|
|
The Clorox Company
|
|
L’Oreal
|
|
Colgate-Palmolive Company
|
|
The Procter and Gamble Company
|
|
Elizabeth Arden, Inc.
|
|
Revlon, Inc.
|
|
The Estée Lauder Company, Inc.
|
|
Unilever PLC
|
|
Inter Parfums, Inc.
|
|
|
|
Target APP Award:
|
|
$500,000 times 50%
|
|
=
|
|
$250,000
|
|
APP total factor:
|
|
(1.30 times 70%) + (1.00 times 30%)
|
|
=
|
|
1.21
|
|
Actual APP Award:
|
|
$250,000 times 1.21
|
|
=
|
|
$302,500
|
|
Name & Title
|
|
Year
|
|
Salary ($)
(1)
|
|
Stock
Awards
($)
(2)
|
|
Option
Awards
($)
(3)
|
|
Non-Equity
Incentive
Plan
Compensation
($)
(1)(4)
|
|
All Other
Compensation
($)
(1)
|
|
Total
Compensation
($)
(1)
|
|||||||||
|
Lambertus J.H. Becht, Interim CEO
|
|
2015
|
|
—
|
|
|
1,000,009
|
|
(5)
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
1,000,009
|
|
|
Michele Scannavini, Former CEO
|
|
2015
|
|
330,880
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
4,391,367
|
|
(6)
|
|
4,722,247
|
|
|
|
|
2014
|
|
1,492,700
|
|
|
3,404,100
|
|
|
|
|
—
|
|
|
1,021,007
|
|
|
—
|
|
|
|
5,917,807
|
|
|
|
|
2013
|
|
1,393,479
|
|
|
4,876,096
|
|
|
|
|
—
|
|
|
516,857
|
|
|
—
|
|
|
|
6,786,432
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
Patrice de Talhouët, CFO
|
|
2015
|
|
765,000
|
|
|
1,418,842
|
|
|
|
|
3,257,357
|
|
|
711,800
|
|
|
256,923
|
|
(7)
|
|
6,409,922
|
|
|
|
|
2014
|
|
375,000
|
|
|
1,137,485
|
|
|
|
|
—
|
|
|
195,075
|
|
|
220,108
|
|
(7)
|
|
1,927,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
Jean Mortier, President of Coty Markets
|
|
2015
|
|
719,995
|
|
|
1,986,000
|
|
|
|
|
5,439,289
|
|
|
793,631
|
|
|
15,335
|
|
(8)
|
|
8,954,250
|
|
|
|
|
2014
|
|
719,210
|
|
|
1,945,200
|
|
|
|
|
—
|
|
|
400,456
|
|
|
17,399
|
|
(8)
|
|
3,082,265
|
|
|
|
|
2013
|
|
667,294
|
|
|
1,550,000
|
|
|
|
|
—
|
|
|
153,866
|
|
|
16,538
|
|
(8)
|
|
2,387,698
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
Jules P. Kaufman, SVP, General Counsel & Secretary
|
|
2015
|
|
492,700
|
|
|
744,750
|
|
|
|
|
3,263,575
|
|
|
441,500
|
|
|
11,278
|
|
(9)
|
|
4,953,803
|
|
|
Mario Reis, EVP, Supply Chain
|
|
2015
|
|
609,997
|
|
|
993,000
|
|
|
|
|
3,257,357
|
|
|
617,030
|
|
|
41,633
|
|
(10)
|
|
5,519,017
|
|
|
(1
|
)
|
|
Mr. Mortier is paid in Euros. Mr. de Talhouët and Mr. Kaufman are paid in U.S. dollars. Mr. Reis is paid in Swiss Francs. Mr. Scannavini was paid in Euros. Mr. Scannavini resigned as CEO effective as of September 30, 2014 and his salary is pro-rated based on his employment termination date. Mr. Becht assumed the role of the interim CEO effective upon Mr. Scannavini’s resignation. Exchange rates for fiscal 2013, 2014 and 2015 compensation are calculated using the weighted average monthly exchange rate during the fiscal year.
|
||||||||||||||||
|
(2
|
)
|
|
Amounts represent the grant date fair value of the RSUs granted on September 30, 2013, January 1, 2014, February 18, 2014 and September 30, 2014 and matching Platinum RSUs granted on January 17, 2013, April 23, 2013, February 21, 2014 and November 7, 2014, in each case calculated in accordance with FASB ASC Topic 718.
|
||||||||||||||||
|
(3
|
)
|
|
Amounts represent the grant date fair value of Options and Series A Preferred Stock granted on April 15, 2015 under the ELTIP, in each case calculated in accordance with FASB ASC Topic 718.
|
||||||||||||||||
|
(4
|
)
|
|
Amounts represent cash awards paid under the APP in October 2013 with respect to fiscal 2013 performance and in October 2014 with respect to fiscal 2014 performance and expected to be paid in October 2015 with respect to fiscal 2015 performance.
|
||||||||||||||||
|
(5
|
)
|
|
Mr. Becht received an award of phantom units granted on December 1, 2014, valued at $1,000,009 based on the closing price of Class A Common Stock on December 1, 2014. This award was granted outside of any equity compensation plan of the Company.
|
||||||||||||||||
|
(6
|
)
|
|
In fiscal 2015, Mr. Scannavini received a car lease valued at $5,967. In addition, pursuant to the Release Agreement (as defined below), Mr. Scannavini received a payment in respect of his non-compete and non-solicitation obligations in the amount of $496,320, a payment in the amount of $904,746, which represents the average amount awarded to Mr. Scannavini under the APP in fiscals 2013 and 2012, a severance indemnity payment in the amount of $1,323,520 and reimbursement for legal fees in the amount of $6,016. Mr. Scannavini also received $1,654,799, which amount represents the difference between the fair market value of the Company’s Class A Common Stock on November 13, 2014 and the Purchase Price for the Repurchase (each as defined below).
|
||||||||||||||||
|
(7
|
)
|
|
In fiscal 2014, we provided Mr. de Talhouët with a car lease valued at $6,487, reimbursement for travel to France valued at $25,988, reimbursement for his children’s school tuition valued at $107,283, plus gross up taxes for such education valued at $69,827. Additionally, in 2014, Mr. de Talhouët received assistance in and reimbursement for the cost of renewing his work permit and visas valued at $10,523. In fiscal 2015, we provided Mr. de Talhouët with a car allowance valued at $4,898 paid in one installment in December 2014, a Company car lease valued at $8,470 for fiscal 2015, reimbursement for travel to France valued at $13,923, reimbursement for children’s school tuition in the amount of $118,555, plus gross up taxes for such education valued at $97,172, and reimbursement for tax assistance in amount of $11,972. Mr. de Talhouët also received a discount of $1,933 on shares purchased on April 15, 2015 from JAB Cosmetics B.V., based on the difference between the purchase price of $24.86 per share and the market closing price of $24.97.
|
||||||||||||||||
|
(8
|
)
|
|
We provided Mr. Mortier with a car lease valued at $16,538 in fiscal 2013, $17,399 in fiscal 2014 and $15,335 in fiscal 2015 for a dual-purpose Company car.
|
||||||||||||||||
|
(9
|
)
|
|
We provided Mr. Kaufman with a car allowance and car lease in the aggregate amount of $11,278.
|
||||||||||||||||
|
(10
|
)
|
|
In fiscal 2015, we provided Mr. Reis with a car allowance in the amount of $7,735 for the period of July 2014 through September 2014 and dual-purpose Company car valued at $24,798 for the period of October 2014 through June 2015. Mr. Reis received a discount of $9,100 on shares purchased on June 12, 2015 from JAB Cosmetics B.V., based on the difference between the purchase price of $25.92 and the market closing price of $26.27.
|
||||||||||||||||
|
Name
|
|
Grant
Date
|
|
Estimated Future Payments
under Non-Equity Incentive
Plan Awards ($)
(1)
|
|
All Other
Stock Awards:
Number of
Shares of
Stock or
Units (#)
(2)
|
|
Grant Date
Fair
Value of
Stock and
Option
Awards ($)
|
|||||||||||||
|
Minimum
|
|
Target
|
|
Maximum
|
|
||||||||||||||||
|
Lambertus J.H. Becht
|
|
12/1/2014
|
|
—
|
|
|
—
|
|
|
—
|
|
|
49,432
|
|
|
|
|
1,000,009
|
|
|
|
|
Michele Scannavini
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
|
|
Patrice de Talhouët
|
|
9/30/2014
|
|
|
|
|
|
|
|
60,000
|
|
|
|
|
993,000
|
|
|
|
|||
|
|
|
11/7/2014
|
|
|
|
|
|
|
|
23,194
|
|
|
|
|
425,842
|
|
|
|
|||
|
|
|
4/15/2015
|
|
|
|
|
|
|
|
621,633
|
|
|
|
|
3,257,357
|
|
|
|
|||
|
|
|
10/2015
|
|
—
|
|
|
459,000
|
|
|
1,652,400
|
|
|
|
|
|
|
|
|
|
||
|
Jean Mortier
|
|
9/30/2014
|
|
|
|
|
|
|
|
120,000
|
|
|
|
|
1,986,000
|
|
|
|
|||
|
|
|
4/15/2015
|
|
|
|
|
|
|
|
621,633
|
|
|
|
|
5,439,289
|
|
|
|
|||
|
|
|
10/2015
|
|
—
|
|
|
539,996
|
|
|
1,943,986
|
|
|
|
|
|
|
|
|
|
||
|
Jules P. Kaufman
|
|
9/30/2014
|
|
|
|
|
|
|
|
45,000
|
|
|
|
|
744,750
|
|
|
|
|||
|
|
|
4/15/2015
|
|
|
|
|
|
|
|
372,980
|
|
|
|
|
3,263,575
|
|
|
|
|||
|
|
|
10/2015
|
|
—
|
|
|
295,620
|
|
|
1,064,232
|
|
|
|
|
|
|
|
|
|
||
|
Mario Reis
|
|
9/30/2014
|
|
|
|
|
|
|
|
60,000
|
|
|
|
|
993,000
|
|
|
|
|||
|
|
|
4/15/2015
|
|
|
|
|
|
|
|
621,633
|
|
|
|
|
3,257,357
|
|
|
|
|||
|
|
|
10/2015
|
|
—
|
|
|
365,998
|
|
|
1,317,593
|
|
|
|
|
|
|
|
|
|
||
|
(1
|
)
|
|
Represents the range of possible payments under the APP based on each NEO’s annual base salary at fiscal year-end. Mr. Mortier will be paid in Euros, and Mr. Reis will be paid in Swiss Francs. Exchange rates for fiscal 2015 compensation are calculated using the weighted average monthly exchange rate during the fiscal year. Awards under the APP are expected to be paid in October 2015.
|
||||||||||||||||
|
(2
|
)
|
|
Represents the annual long-term incentive compensation award of Restricted Stock Units under the ELTIP and matching Platinum RSUs. Also represents Options and Series A Preferred Stock under the ELTIP, and phantom units not granted pursuant to any equity compensation plan of the Company.
|
||||||||||||||||
|
|
|
Target
|
|
Minimum
|
|
Below
|
|
Target
|
|
Exceeds
|
|
Maximum
|
|
Actual
|
||||||||||||||||||||||||||
|
|
|
Improvement
over prior year |
|
Delta
(bps) with Target |
|
Payout
(Factor) |
|
Delta
(bps) with Target |
|
Payout
(Factor) |
|
Delta
(bps) with Target |
|
Payout
(Factor) |
|
Delta
(bps) with Target |
|
Payout
(Factor) |
|
Delta
(bps) with Target |
|
Payout
(Factor) |
|
Delta
(bps) with Target |
|
Payout
(Factor) |
||||||||||||||
|
Net Income Attributable to Coty Inc. Growth YOY (40%)
|
|
0
|
%
|
|
|
(1,000
|
)
|
|
—
|
|
|
(500
|
)
|
|
0.2
|
|
|
—
|
|
|
0.4
|
|
|
200
|
|
|
0.8
|
|
|
400
|
|
|
1.44
|
|
|
1,245
|
|
|
1.44
|
|
|
Net Revenues Growth YOY (40%)
|
|
2.3
|
%
|
|
|
(230
|
)
|
|
—
|
|
|
(130
|
)
|
|
0.2
|
|
|
—
|
|
|
0.4
|
|
|
120
|
|
|
0.8
|
|
|
220
|
|
|
1.44
|
|
|
(195
|
)
|
|
0.07
|
|
|
Average NWC as % of Rolling Sales Improvement YOY in basis point (20%)
|
|
130
|
|
|
|
(130
|
)
|
|
—
|
|
|
(65
|
)
|
|
0.1
|
|
|
—
|
|
|
0.2
|
|
|
25
|
|
|
0.4
|
|
|
50
|
|
|
0.72
|
|
|
(164
|
)
|
|
—
|
|
|
TOTAL
|
|
|
|
|
|
—
|
|
|
|
|
0.5
|
|
|
|
|
1.0
|
|
|
|
|
2.0
|
|
|
|
|
3.60
|
|
|
|
|
1.51
|
|
||||||||
|
Name
|
|
|
Salary ($)
(1)
|
|
Award
Target
Relative to
Salary (%)
|
|
Award
Minimum ($)
|
|
Award
Maximum ($)
|
|
Award
Target ($)
|
|
Actual
APP
Factor
|
|
Actual
Award ($)
(2)
|
|||||||
|
Lambertus J.H. Becht
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Michele Scannavini
|
(3)
|
|
1,323,520
|
|
|
100
|
%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Patrice de Talhouët
|
|
|
765,000
|
|
|
60
|
%
|
|
—
|
|
|
1,652,400
|
|
|
459,000
|
|
|
1.551
|
|
|
711,800
|
|
|
Jean Mortier
|
|
|
719,995
|
|
|
75
|
%
|
|
—
|
|
|
1,943,986
|
|
|
539,996
|
|
|
1.466
|
|
|
793,631
|
|
|
Jules P. Kaufman
|
|
|
492,700
|
|
|
60
|
%
|
|
—
|
|
|
1,064,232
|
|
|
295,620
|
|
|
1.493
|
|
|
441,500
|
|
|
Mario Reis
|
|
|
609,997
|
|
|
60
|
%
|
|
—
|
|
|
1,317,593
|
|
|
365,998
|
|
|
1.643
|
|
|
617,030
|
|
|
(1
|
)
|
|
Represents annual base salary as of June 30, 2015. In fiscal 2015 Mr. Mortier was paid in Euros and Mr. Reis was paid in Swiss Francs. Exchange rates for fiscal 2015 compensation are calculated using the weighted average monthly exchange rate during the fiscal year.
|
||||||||||||||||
|
(2
|
)
|
|
Actual award amounts are calculated based on each NEO’s annual base salary in the local currency in which they are paid. Exchange rates for fiscal 2015 compensation are calculated using the weighted average monthly exchange rate during the fiscal year.
|
||||||||||||||||
|
(3
|
)
|
|
Mr. Scannavini was not eligible to receive an APP award for fiscal 2015 performance.
|
||||||||||||||||
|
NEO
|
|
Series A Preferred Stock
|
|
Options
|
|
Class A Common Stock Ownership (Maximum Investment Amount)
|
|
Scheduled Vesting Date
|
||
|
|
Award Granted
|
Cash Conversion Factor
|
|
Award Granted
|
Exercise Price
|
|
||||
|
Patrice de Talhouët
|
|
621,633
|
$27.97
|
|
|
|
|
207,211
|
|
April 15, 2020
|
|
Jules P. Kaufman
|
|
|
|
|
372,980
|
$24.13
|
|
124,327
|
|
April 15, 2020
|
|
Jean Mortier
|
|
|
|
|
621,633
|
$24.13
|
|
207,211
|
|
April 15, 2020
|
|
Mario Reis
|
|
621,633
|
$27.97
|
|
|
|
|
207,211
|
|
April 15, 2020
|
|
NEO
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||||
|
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
(1)
|
|
Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#)
(1)
|
|
Option
Exercise
Price
($)
|
|
Option
Expiration
Date
|
|
Number of
Shares or
Units of
Stock
That Have
Not
Vested (#)
|
|
Market
Value of
Shares or
Units of
Stock
That Have
Not
Vested ($)
|
|||||||||||
|
Lambertus J.H. Becht
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
49,432
|
|
(2)
|
|
|
1,580,341
|
|
|
Michele Scannavini
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
Patrice de Talhouët
|
|
|
|
621,633
|
|
(3)
|
|
27.97
|
|
|
4/15/2022
|
|
|
23,194
|
|
(4)
|
|
|
741,512
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
(5)
|
|
|
1,918,200
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
2,591
|
|
(6)
|
|
|
82,834
|
|
||||
|
Jules P. Kaufman
|
|
75,000
|
|
|
|
|
|
6.40
|
|
|
1/7/2019
|
|
|
45,000
|
|
(5)
|
|
|
1,438,650
|
|
|
|
|
|
110,250
|
|
|
|
|
|
6.40
|
|
|
3/2/2019
|
|
|
45,000
|
|
(7)
|
|
|
1,438,650
|
|
|
|
|
|
75,000
|
|
|
|
|
|
8.25
|
|
|
9/8/2019
|
|
|
1,092
|
|
(8)
|
|
|
1,198,875
|
|
|
|
|
|
|
|
170,000
|
|
|
|
9.20
|
|
|
9/14/2020
|
|
|
37,500
|
|
(9)
|
|
|
34,911
|
|
|
|
|
|
|
|
212,630
|
|
|
|
9.20
|
|
|
12/3/2020
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
190,000
|
|
|
|
10.50
|
|
|
9/22/2021
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
230,600
|
|
|
|
10.50
|
|
|
1/10/2022
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
372,980
|
|
|
|
24.13
|
|
|
4/15/2025
|
|
|
|
|
|
|
|
|||
|
Jean Mortier
|
|
100,000
|
|
|
|
|
|
10.20
|
|
|
9/10/2017
|
|
|
120,000
|
|
(5)
|
|
|
3,836,400
|
|
|
|
|
|
199,700
|
|
|
|
|
|
10.20
|
|
|
11/1/2017
|
|
|
120,000
|
|
(7)
|
|
|
3,836,400
|
|
|
|
|
|
100,000
|
|
|
|
|
|
6.40
|
|
|
1/7/2019
|
|
|
100,000
|
|
(8)
|
|
|
3,197,000
|
|
|
|
|
|
55,000
|
|
|
|
|
|
8.25
|
|
|
9/8/2019
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
115,000
|
|
|
|
9.20
|
|
|
9/14/2020
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
74,980
|
|
|
|
9.20
|
|
|
12/3/2020
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
165,000
|
|
|
|
10.50
|
|
|
9/22/2021
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
140,468
|
|
|
|
10.50
|
|
|
1/10/2022
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
621,633
|
|
|
|
24.13
|
|
|
4/15/2025
|
|
|
|
|
|
|
|
|||
|
Mario Reis
|
|
|
|
621,633
|
|
(3)
|
|
27.97
|
|
|
4/15/2022
|
|
|
60,000
|
|
(5)
|
|
|
1,918,200
|
|
|
|
(1
|
)
|
|
Each of the Stock Options, matching options under the EOP (“Matching Options”) and Options described in this table expires ten years after the grant date. All Stock Options, Matching Options and Options vest on the fifth anniversary of the grant date, subject to certain vesting conditions. All Series A Preferred Stock described in this table expire after seven years and vest on the fifth anniversary of the grant date, subject to certain vesting conditions. Mr. Scannavini had no outstanding equity at 2015 fiscal year end.
|
|
(2
|
)
|
|
Represents phantom units granted on December 1, 2014. The phantom units vest on the fifth anniversary of the grant date, subject to certain vesting conditions. Mr. Becht also received RSUs granted under the 2007 Director Plan in connection with his services as Chairman of the Board. The grants of 30,000, 30,000, 30,000 and 22,500 RSUs were granted in November 2014, 2013, 2012 and 2011, respectively, and vest five years after the grant date.
|
|
(3
|
)
|
|
Represents Series A Preferred Stock granted under the ELTIP on April 15, 2015 that vest five years after the grant date, subject to certain vesting conditions.
|
|
(4
|
)
|
|
Represents matching Platinum RSUs granted on November 7, 2014 in connection with purchase of stock under Platinum. Platinum RSUs vest on the fifth anniversary of the grant date, subject to certain vesting conditions.
|
|
(5
|
)
|
|
Represents RSUs granted under the ELTIP on September 30, 2014 that vest five years after the grant date.
|
|
(6
|
)
|
|
Represents matching Platinum RSUs granted on February 21, 2014 in connection with purchase of stock under Platinum.
|
|
(7
|
)
|
|
Represents RSUs granted under the ELTIP on September 30, 2013 that vest five years after the grant date.
|
|
(8
|
)
|
|
Represents matching Platinum RSUs granted on January 17, 2013 in connection with purchase of stock under Platinum.
|
|
(9
|
)
|
|
Represents RSUs granted under the LTIP on September 25, 2012 that vest five years after the grant date.
|
|
NEO
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||
|
Number of
shares
acquired on
exercise (#)
|
|
Value
realized on
exercise ($)
(1)
|
|
Number of
shares
acquired on
vesting (#)
|
|
|
Value
realized on
vesting ($)
|
|
|||||||
|
Lambertus J.H. Becht
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
Michele Scannavini
|
|
1,424,700
|
|
(2)
|
|
10,669,435
|
|
|
—
|
|
|
|
—
|
|
|
|
Patrice de Talhouët
|
|
—
|
|
|
|
—
|
|
|
72,522
|
|
(3)
|
|
1,797,095
|
|
(4)
|
|
Jules P. Kaufman
|
|
150,000
|
|
(5)
|
|
1,459,365
|
|
|
—
|
|
|
|
—
|
|
|
|
Jean Mortier
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
|
Mario Reis
|
|
—
|
|
|
|
—
|
|
|
100,000
|
|
|
|
2,478,000
|
|
(4)
|
|
(1
|
)
|
|
Represents the difference between the closing price of the Class A Common Stock on the exercise date and the exercise price multiplied by the number of shares underlying each option exercised.
|
||||||||||||||||
|
(2
|
)
|
|
404,700 options exercised were granted on November 1, 2007 at an exercise price of $10.20; 300,000 options exercised were granted on January 7, 2009 at an exercise price of $6.40; 200,000 options exercised were granted on September 8, 2009 at an exercise price of $8.25; 520,000 options exercised were granted on September 14, 2010 at an exercise price of $9.20 and were subject to accelerated vesting pursuant to the Release Agreement.
|
||||||||||||||||
|
(3
|
)
|
|
Represents the accelerated vesting and settlement of 51,381 RSUs from January 1, 2019 to April 14, 2015 and 21,141 RSUs from February 18, 2019 to April 14, 2015.
|
||||||||||||||||
|
(4
|
)
|
|
Represents the difference between the closing price of the Class A Common Stock on the vesting date and the grant date multiplied by the number of shares underlying each RSU vested.
|
||||||||||||||||
|
(5
|
)
|
|
150,000 options exercised were granted on January 2, 2008 at an exercise price of $10.20.
|
||||||||||||||||
|
•
|
Mr. de Talhouët is entitled to 90-days base salary if his employment is terminated due to resignation or retirement and 12 months base salary if his employment is terminated without cause.
|
|
•
|
Mr. Kaufman is entitled to 12 months base salary if his employment is terminated without cause or due to resignation with good reason, base salary for 13 weeks (minus any sums granted under statutory sick pay or Company-funded insurance) in the case of disability and one month base salary if his employment is terminated due to death.
|
|
•
|
Mr. Mortier is entitled to two-thirds of average gross salary (including his target APP award) for up to 12 months if his employment is terminated for any reason in consideration of the competition restrictions within his employment agreement.
|
|
•
|
Mr. Reis is entitled to 12 months base salary if his employment is terminated without cause.
|
|
Name
|
|
Resignation
with Good
Reason
|
|
Termination
without
cause
|
|
Termination
for cause
|
|
Resignation
without
Good Reason
|
|
Disability,
Retirement
or death
|
|
Change in
Control
(1)
|
|
Resignation
with Good
Reason or
Termination
without
Cause after
Change in
Control
(2)
|
|||||||||
|
Lambertus J.H. Becht
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
|
|
Patrice de Talhouët
|
|
188,630
|
|
|
765,000
|
|
|
—
|
|
|
188,630
|
|
|
3,603,168
|
|
(3)
|
|
918,000
|
|
|
5,417,709
|
|
(4)
|
|
Jules P. Kaufman
|
|
492,700
|
|
|
492,700
|
|
|
—
|
|
|
—
|
|
|
16,618,036
|
|
(5)
|
|
9,303,725
|
|
|
16,558,231
|
|
|
|
Jean Mortier
|
|
839,994
|
|
|
839,994
|
|
|
839,994
|
|
|
839,994
|
|
|
13,563,710
|
|
|
|
5,405,837
|
|
|
23,141,795
|
|
|
|
Mario Reis
|
|
—
|
|
|
609,997
|
|
|
—
|
|
|
—
|
|
|
3,390,492
|
|
|
|
731,996
|
|
|
4,404,732
|
|
(6)
|
|
(1
|
)
|
|
Includes accelerated vesting of stock options granted before March 2011, the date we amended our LTIP and EOP to require a “double-trigger” for accelerated vesting in connection with a change in control of the Company.
|
|
(2
|
)
|
|
Incremental payments represented in this column do not include any incremental payments reported in the column labeled “Change in Control” that the NEO is entitled to receive pursuant to such change in control.
|
|
(3
|
)
|
|
Represents incremental payments Mr. de Talhouët is entitled to receive upon termination of his employment due to his disability or death. Mr. de Talhouët is entitled to receive an additional $188,630 upon his retirement.
|
|
(4
|
)
|
|
Represents incremental payments Mr. de Talhouët is entitled to receive if he had resigned for good reason after a change in control. Mr. de Talhouët is entitled to receive an additional $576,370 if his employment had been terminated without cause after a change in control.
|
|
(5
|
)
|
|
Represents incremental payments Mr. Kaufman is entitled to receive upon termination of his employment due to his retirement. Mr. Kaufman is entitled to receive an additional $41,058 upon termination due to death and an additional $123,175 upon termination due to disability.
|
|
(6
|
)
|
|
Represents incremental payments Mr. Reis is entitled to receive if he had resigned for good reason after a change in control. Mr. Reis is entitled to receive an additional $609,997 if his employment had been terminated without cause after a change in control.
|
|
1.
|
Reviewed and discussed the Company’s audited financial statements for the fiscal year ended June 30, 2015 with management;
|
|
2.
|
Discussed with Deloitte & Touche LLP (“Deloitte & Touche”) the matters required to be discussed under Public Company Accounting Oversight Board standards; and
|
|
3.
|
Received the written disclosures and the letter from Deloitte & Touche LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding Deloitte & Touche LLP’s communications with the AFC concerning independence and has discussed with Deloitte & Touche LLP their independence from management and the Company.
|
|
Fee Type
|
|
Fiscal 2015
(in thousands) |
|
Fiscal 2014
(in thousands) |
||||
|
Audit Fees
(1)
|
|
$
|
7,041
|
|
|
$
|
7,489
|
|
|
Audit-Related Fees
(2)
|
|
236
|
|
|
509
|
|
||
|
Tax Fees
(3)
|
|
1,967
|
|
|
2,033
|
|
||
|
All Other Fees
(4)
|
|
141
|
|
|
1,270
|
|
||
|
Total
|
|
$
|
9,385
|
|
|
$
|
11,301
|
|
|
(1
|
)
|
This category represents the fees associated with the annual audit and the audit of internal control over financial reporting and international statutory audit requirements.
|
|
(2
|
)
|
This category includes fees paid for professional services associated with the preparations for its certification of internal controls as required by the Sarbanes-Oxley Act and agreed upon procedures for one of our licenses.
|
|
(3
|
)
|
This category represents the fees for tax-related services, including tax compliance, tax advice, and tax planning.
|
|
(4
|
)
|
This category represents all other fees that are not included in the above categories, and represents primarily fees paid for management consulting services and $16,000 in fees paid for benchmarking and the provision of other data related to management compensation arrangements.
|
|
|
|
By order of the Board of Directors,
|
|
|
|
|
|
|
|
|
|
|
|
Jules P. Kaufman
|
|
|
|
|
|
Senior Vice President, General Counsel and Secretary
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|